Skip to main navigation
Skip to search
Skip to main content
Ariel University Home
Help & FAQ
Link opens in a new tab
English
עברית
العربية
Search content at Ariel University
Home
Profiles
Research units
Equipment
Research output
Prizes
Activities
Press/Media
No. 274-Management of Varicella Infection (Chickenpox) in Pregnancy
Alon Shrim
, Gideon Koren
, Mark H. Yudin
, Dan Farine
Research output
:
Contribution to journal
›
Article
›
peer-review
20
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'No. 274-Management of Varicella Infection (Chickenpox) in Pregnancy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
During Pregnancy
100%
Varicella
100%
Varicella-zoster Virus Infection
100%
Chickenpox
100%
Varicella Zoster Immunoglobulin
66%
Pregnant Women
50%
Varicella Vaccine
50%
Pneumonitis
50%
Fetus
33%
Non-immune
33%
Infections In Pregnancy
33%
Acyclovir
33%
Peripartum Management
33%
Rash
16%
Neonate
16%
Immunoglobulin G
16%
Termination of Pregnancy
16%
Maternal Infection
16%
Severe Complications
16%
MEDLINE
16%
Pregnancy Complications
16%
Prenatal Diagnosis
16%
Fetal Outcome
16%
Existing Data
16%
Ultrasound
16%
Neonatal Care
16%
Maternal Complications
16%
Immunization
16%
Clinical Practice Guidelines
16%
Canadian Task Force on Preventive Health Care
16%
Serology
16%
Treatment Modalities
16%
Maternal Outcomes
16%
Admission to Hospital
16%
Immune Status
16%
Maternal-fetal
16%
Vaccination in Pregnancy
16%
Peripartum
16%
Fetal Infection
16%
Medical Assistance
16%
Postpartum Care
16%
Immunological Status
16%
Pregnancy Care
16%
Recommendations for Practice
16%
Transmission Risk
16%
Low Bioavailability
16%
Pregnancy Intervention
16%
Serum Testing
16%
Oral Antivirals
16%
Healthcare Providers
16%
After Delivery
16%
Early Neonatal
16%
Oral Forms
16%
Previous Infection
16%
Neonatal Healthcare
16%
Medicine and Dentistry
Chickenpox
100%
Herpes Zoster Immunoglobulin
26%
Pregnant Woman
20%
Infection
13%
Aciclovir
13%
Sequela
13%
Disseminated Herpes Zoster
13%
Oral
13%
Neonatal Health
6%
Maternal Disease
6%
Puerperium
6%
Newborn Care
6%
Preventive Medicine
6%
Clinical Guideline
6%
Neonate
6%
Exanthem
6%
Prenatal Diagnosis
6%
Immunoglobulin G
6%
Antivirus Agent
6%
Bioavailability
6%
Prepregnancy Care
6%
Health Care Personnel
6%
Treatment Modality
6%